Great expectations for a new vaccine

New England Journal of Medicine

Volumn 349, Issue 14, 2003, Pages 1312-1314

  Edwards, Kathryn M ^a   Griffin, Marie R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

HUMAN; IMMUNIZATION; INFECTION PREVENTION; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0141430937     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp038102     Document Type: Review

References (4)

1. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-55.
2. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46.
3. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.
4. French N, Nakiyingi J, Carpenter LM, et al. 23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. Lancet 2000;355:2106-11.